Amended Contractors Classification Law regulations set criteria for dividing major projects    Saudi Arabia emerges global leader in charitable and relief work with over SR528 billion in aid    20,882 violators of residency, border security, and labor laws arrested in a week    Saudi Arabia to head Arab Experts Group on Counter-Terrorism    Over 47,000 transport violations detected during 340,000 TGA inspections in August    Israel orders Gaza City evacuation, bombs high-rise towers    Modi welcomes Trump's remarks on India-US ties despite tariff tensions    British lawmakers urge boycott of Israeli President Herzog's visit    Saudi Arabia condemns Israeli calls for Palestinian displacement, backs Egypt's stance    Saudi Arabia's digital sector grows to 389,000 workers with record female participation    Riyadh Metro adjusts start time to 5:30 AM to serve commuters and students    Mike Tyson and Floyd Mayweather Jr. set to meet in exhibition boxing match in 2026    Gamers frustrated as Hollow Knight: Silksong crashes stores on launch    'My mother was my shelter and storm': Arundhati Roy on her fierce new memoir    HONOR to participate in Global Symposium for Regulators 2025 in Saudi Arabia    Restored Big Ben tower up for architecture award    NVIDIA GeForce RTX 50 Series laptops redefine learning, creating and gaming    Al Ahli secure Flamengo starlet Matheus Gonçalves in long-term deal through 2027    Al Hilal sign Turkish defender Yusuf Akcicek on €22m deal until 2029    Al Qadsiah sign German midfielder Julian Weigl to strengthen defensive midfield    Sholay: Bollywood epic roars back to big screen after 50 years with new ending    Ministry launches online booking for slaughterhouses on eve of Eid Al-Adha    Shah Rukh Khan makes Met Gala debut in Sabyasachi    Pakistani star's Bollywood return excites fans and riles far right    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Study: Oxford COVID-19 vaccine is safe and triggers response in adults over 56
Published in The Saudi Gazette on 19 - 11 - 2020

Phase 2 trials of Oxford University's COVID-19 vaccine in healthy older adults have found it is safe and provokes an immune response.
The university confirmed that the candidate vaccine it is developing with AstraZeneca showed similar safety and immunogenicity results in healthy older people (aged 56 and over) to those seen in adults aged 18-55 years.
Older people are at a disproportionate risk of severe COVID-19 disease, so it is essential that any vaccine adopted for use is effective in this group.
The early-stage results, which they described as "promising" were published Thursday in The Lancet medical journal.
The phase 2 trial, which involved 560 adults including 240 over the age of 70, found that the vaccine causes few side effects and induces immune responses in both parts of the immune system in all age groups.
Results showed within 14 days of the first dose of vaccination it provoked a T cell response — it could find and attack cells infected with the virus — and caused an antibody response within 28 days of the booster jab.
Phase 3 trials, which involve thousands of participants, are ongoing to confirm these results, as well as how effective the vaccine is in protecting against infection with SARS-CoV-2 (the strain of the virus that causes coronavirus disease) in a broader range of people, including older adults with underlying health conditions, according to the vaccine's developers
"Immune responses from vaccines are often lessened in older adults because the immune system gradually deteriorates with age, which also leaves older adults more susceptible to infections," said study lead author, Professor Andrew Pollard from the University of Oxford.
"As a result, it is crucial that COVID-19 vaccines are tested in this group who are also a priority group for immunization."
Late-stage trial results will show if the Astra-Oxford vaccine can meet the standard set by front-runners Pfizer-BioNTech and Moderna.
Pfizer and BioNTech said Wednesday that the coronavirus vaccine they were developing has been proved 95 percent effective overall, with efficacy in adults over 65 years of age at 94 percent.
The US and German pharmaceuticals organizations said the candidate now met the safety criteria needed for emergency authorization.
US biotechnology company Moderna said on Monday that, based on preliminary data, their potential coronavirus vaccine has been deemed to be 94.5 percent effective at preventing people from getting the virus.
Trials for the Astra-Oxford vaccine candidate were paused in September after a participant fell ill.
They were restarted again after the company had investigated whether a vaccine recipient's "potentially unexplained" illness was a result of receiving the jab.
In large trials like this one, "it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety," the Oxford University said.
It did not disclose medical information about the illness that caused the trial to be put on hold, citing participant confidentiality.
Health experts, including the UK government's chief scientific adviser, Sir Patrick Vallance, have said pauses in drug trials are commonplace to ensure safety and effectiveness. — Courtesy Euro mews


Clic here to read the story from its source.